Sorry to correct you again. The point is patent can be extended like RAC did, that's how they work. The important asset for drug to market is Fast Track designation and not patent.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.1¢ | $376.2K | 32.83M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 3534042 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 11298051 | 21 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |